Press Release Vivacta Bio Announces Promising First-in-Human Results for GT801, an In Vivo CAR-T Therapy, in Non-Hodgkin’s Lymphoma at the 2025 ASH Annual Meeting 6 December 2025
Press Release Viatris Announces Agreement to Monetize its Equity Stake in Biocon Biologics Limited 6 December 2025
Press Release Advances in Technology Help Improve Safety and Access to Blood Cancer Therapies 6 December 2025
Press Release MemeMax, MemeCore’s First Perp DEX, Extends MaxPack Event Ahead of January Launch After 400% Network Surge 6 December 2025
Press Release PCs for People Announces Departure of Cofounder and CEO Casey Sorensen After 18 Years of Leadership 6 December 2025
Press Release Strutt ev¹ the CES 2026 Best of Innovation Winner Announces Super Early Bird Begins 6 December 2025
Press Release Children’s Education Franchise COMPUCHILD Expands Further Into Santa Clara County, California 5 December 2025
Press Release Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 5 December 2025
Press Release AL-S Pharma Reports Positive Results from Phase 2 Study of AP-101 for the Treatment of ALS, Supporting Plans for a Confirmatory Phase 3 Study 5 December 2025
